Clinical Pharmacology: Current Topics and Case Studies - neues Buch

EAN (ISBN-13): 9783709101445
ISBN (ISBN-10): 3709101441
Erscheinungsjahr: 2011
Herausgeber: Springer Wien
430 Seiten
Sprache: eng/Englisch

Buch in der Datenbank seit 2011-09-19T12:10:00+02:00 (Zurich)
Detailseite zuletzt geändert am 2023-01-29T11:22:52+01:00 (Zurich)
ISBN/EAN: 9783709101445

ISBN - alternative Schreibweisen:
3-7091-0144-1, 978-3-7091-0144-5
Alternative Schreibweisen und verwandte Suchbegriffe:
Autor des Buches: markus müller
Titel des Buches: pharmacology

---

Daten vom Verlag:

Autor/in: Markus Müller
Titel: Clinical Pharmacology: Current Topics and Case Studies
Verlag: Springer; Springer Wien
430 Seiten
Erscheinungsjahr: 2011-02-04
Vienna; AT
Sprache: Englisch
245,03 € (DE)
245,03 € (AT)
282,00 CHF (CH)
Available
XXIV, 430 p.

EA; E107; eBook; Nonbooks, PBS / Medizin/Pharmazie; Pharmakologie; Verstehen; Alzheimer; clinical research; clinical trial; drug; drug development; drug research; ethics; gene therapy; kinetics; pharmacodynamics; pharmacokinetics; pharmacology; research; siRNA; vaccine; B; Pharmacology/Toxicology; Pharmacy; Pharmacology; Pharmacy; Biomedical and Life Sciences; Pharmazie, Apotheke; BB

1. Introduction The discipline of Clinical Pharmacology Markus Müller; Professor of Clinical Pharmacology, Vienna, Austria Example: EACPT – position paper Current issues in drug development Markus Müller; Professor of Clinical Pharmacology, Vienna, Austria Example: Pfizer Current issues in drug regulation Marcus Müllner / Hans Georg Eichler; Professor and Head, Austrian Medicines Agency AGES, Vienna, Austria / Professor and Senior Medical Officer, EMEA, London, UK Example: EMEA Current issues in drug reimbursement Anna Bucsics; Medical Director, Austrian Board of Social Security Institutions Example: comparative effectiveness 2. Clinical Trials Ethics of clinical research Ernst Singer; Professor and Head, Ethics Committee, Medical University Vienna, Austria Example: Nürnberg, Helsinki, Belmont GCP, Scientific misconduct Brigitte Blöchl-Daum; Professor of Clinical Pharmacology, Vienna, Austria Example: Tuskegee, Vioxx Phases of drug development, first in man studies Bernd Jilma; Professor of Clinical Pharmacology, Vienna, Austria Example: Tegenero Clinical trials – interventional studies Michael Wolzt; Professor of Internal Medicine, Vienna, Austria Example: CAST Clinical trials – observational studies Ch. Male / H. Herkner; Professor of Pediatrics, Vienna, Austria/ Professor of Internal Medicine, Vienna, Austria Example: CDC 'Outbreak' Pharmacokinetics / Pharmacodynamics Hartmut Derendorf; Professor of Pharmaceutics, University of Florida, USA Example: Antibiotic drug development Microdosing Graham Lappin; Medical Director, Exceleron, UK Example: CREAM trial Epidemiology, statistics L.Schmetterer / G.Garhöfer; Professor of Physics, Vienna, Austria/ Professor of Clinical Pharmacology, Vienna, Austria Example: Star signs (multiple hypothesis testing) Placeboeffects Johannes Pleiner; Professor of Clinical Pharmacology, Vienna, Austria Example: Arthroscopy 3. Tools in Clinical Pharmacology Imaging Oliver Langer; Professor of Radiopharmaceutics, Vienna, Austria Example: Aprepitant Genomics, Pharmacogenomics, druggable genome Wolfgang Schmidt; Consultant of Genetics, Vienna, Austria Example: Abacavir Biomarkers Volker Wacheck; Consultant of Internal Medicine, Vienna, Austria Example: Cholesterol Molecular tools in drug research - translational medicine Volker Wacheck; Consultant of Internal Medicine, Vienna, Austria Example: knockout animals - ACE2 (Apeiron) 4. Topics in Clinical Pharmacology Pharmaceutical drug safety Martin Brunner; Professor of Clinical Pharmacology, Vienna, Austria Example: Lipobay Drug Interactions Markus Zeitlinger; Professor of Clinical Pharmacology, Vienna, Austria Example: Saint-John’s-wort Biological pharmaceuticals: antibodies, proteins, siRNAs Markus Müller; Professor of Clinical Pharmacology, Vienna, Austria Example: Alzheimer Vaccine Advanced therapies Bernd Jilma; Professor of Clinical Pharmacology, Vienna, Austria Example: Gene Therapy Individualization Markus Müller; Professor of Clinical Pharmacology, Vienna, Austria Example: breast cancer Generic drugs, Enantiomers, mee-too´s, biosimilars Brigitte Blöchl-Daum; Professor of Clinical Pharmacology, Vienna, Austria Example: PPIs Special situations, market fragmentation 1: Pediatric and elderly populations, Orphan drugs Brigitte Blöchl-Daum/ Christoph Male; Professor of Clinical Pharmacology, Vienna, Austria Professor of Pediatrics, Vienna, Austria Example: EMEA pediatric plan Special situations, market